Do you need a license to sell peptides in Maryland?

There is no standalone "peptide license" to apply for, and that is precisely why this question is hard to answer cleanly. What a business actually needs depends on which of three separate tracks it sits on: ordinary business registration and tax licensing that applies to any company operating and selling in the state; product classification, which is what determines whether drug or device distribution rules and wholesale distributor permitting come into play; and the research-use-only supply lane, where material is sold for laboratory research and never for human consumption. Those tracks are governed by different authorities and resolved by different filings. This article maps the questions and the order to ask them in — an attorney licensed in Maryland and the relevant state board provide the answers. It is informational, not legal advice.

Three questions get compressed into one

When an operator asks whether they need a license, they are usually asking three things at once without separating them.

The first is a permission-to-operate question: is my entity properly registered and authorized to do business and collect tax in this state? That one is procedural and applies whether you sell peptides, protein powder, or office furniture.

The second is a classification question: what is the thing I am selling, in the eyes of the law? This is the hinge. Nothing downstream can be answered until it is resolved, because permitting obligations attach to categories — drugs, devices, prescription articles, general merchandise, research chemicals — not to the word "peptide."

The third is a role question: what am I in the transaction chain? Manufacturer, wholesale distributor, retail reseller, or end purchaser? Different roles trigger different registrations, and a business model can shift roles without the owner noticing — for example, when a company begins holding inventory and shipping to other businesses rather than buying for its own use.

Operators get into trouble by answering question one, seeing a business license in their hand, and assuming questions two and three are settled. They are not related. Registration makes you a lawful business; it says nothing about whether a specific product may lawfully move through your hands.

What general business registration settles, and what it leaves open

In most states, the baseline is familiar: form or foreign-qualify the entity, register a trade name if you use one, obtain a tax account for sales and use tax where applicable, secure any resale or exemption certificates you intend to rely on, and check whether your county or municipality imposes its own licensing on the kind of commerce you are doing. Home-based and warehouse-based operations sometimes face additional local requirements around zoning and storage.

These steps are durable and mostly clerical. They are also the easiest part of the analysis, which is why they get mistaken for the whole of it. A resale certificate lets you buy inventory without paying tax at the point of purchase. It is not a determination by any regulator that the inventory in question is lawful for you to distribute. Confirm your specific obligations with the state's business registration authority and with counsel, because filing categories and local overlays vary.

The classification question drives everything downstream

Whether a wholesale distributor permit, pharmacy-board registration, or any additional authorization is required generally turns on how the article you are moving is classified — and classification is not purely a matter of chemistry. How a product is labeled, described, and marketed can bear on how regulators view it. Two shipments of identical material can sit in different regulatory categories because of the claims attached to them.

That is the part most operators underestimate. A supplier's terms of sale, your own product page copy, your email marketing, your social posts, and even what a sales rep says on a call all form part of the picture counsel will look at. If any of it describes a compound as something people take, the analysis changes.

So the productive question is not "is a license required to sell peptides?" It is: given exactly how my business describes and distributes this specific material, to these specific buyers, what category does it fall in, and what registrations attach to that category? Bring that framing to an attorney licensed in Maryland, and where distribution or permitting is in question, to the Maryland Board of Pharmacy. Do not accept a general answer from an online forum, a supplier, or a competitor's website — including this one.

Mapping each question to the right authority

Use this to organize the conversation rather than to conclude it. Every row ends with a person to ask, not an answer to rely on.

Research-use-only is a set of obligations, not a loophole

Operators sometimes treat "research use only" as a phrase that neutralizes risk. It does not work that way. RUO is a description of what the material is supplied for, and it only holds if the entire business behaves consistently with it.

In practice that means labeling that states the research-use-only limitation plainly and stays on the container. It means terms of sale that say the same thing, applied to every order rather than to some. It means product descriptions with no human-use framing anywhere — no suggested amounts, no administration guidance, no before-and-after imagery, no language describing what someone might experience. It means not packaging compounds together with administration supplies in a way that implies a ready-to-use kit for a person. It means your sales conversations follow the same rules as your written copy, because a screenshot of a chat message is as much a record as a label.

It also means documentation discipline: keeping the certificate of analysis that corresponds to each lot you received, tying that lot to what you shipped out, and retaining purchase and customer records. If a question ever arrives, the difference between a manageable conversation and a serious one is usually whether the paperwork exists and matches.

None of this substitutes for legal review of your specific model. It is the baseline hygiene that makes legal review productive instead of alarming.

How to vet a wholesale supplier before your first order

Once the licensing questions are with your counsel, supplier due diligence is the part you control entirely. The market rewards buyers who ask uncomfortable questions early.

Start with testing. Ask what method the purity figure comes from, whether it is HPLC, and whether the number is reported per production lot or as a general specification. A specification is a target; a batch result is evidence. Ask what else is tested beyond purity — identity confirmation and contamination panels tell you very different things about a lot than a single purity percentage does.

Then check how documentation is delivered. Certificates of analysis that are publicly viewable let you verify a lot before you commit. COAs available only on request, gated behind an account, or sold as a paid add-on shift the burden onto you and make comparison shopping between suppliers nearly impossible. Confirm the lot number on the certificate matches the lot number on the vial you receive, and archive both.

Look at pricing transparency next. Quote-only pricing with no published structure makes it difficult to model your costs or to know whether you are being quoted the same terms as the buyer before you. Ask whether tier thresholds and minimums are published, and whether they change without notice.

Finally, look at fulfillment and terms. Where do orders ship from, what happens if a lot fails your incoming inspection, and do the terms of sale state the research-use-only limitation in writing? Suppliers that route through customs add variables to your lead times that you cannot manage from your end.

What Real Peptides does differently

Real Peptides runs its wholesale side on documentation the buyer can check without asking permission. Products are supplied at 99%+ HPLC purity, with 6-panel batch testing performed at the lot level rather than as a one-time specification sheet. The certificates of analysis are publicly verifiable — a prospective partner can review lab results before applying, rather than after committing to an order or paying separately for the paperwork.

Fulfillment is handled from within the United States, with approved wholesale orders shipping in five to seven days, which removes customs from the lead-time equation. Wholesale access runs through a three-step application: submit your business information, receive an approval decision, then order at partner pricing. Pricing tiers are presented up front rather than negotiated case by case behind a quote form.

Everything supplied is research use only. Real Peptides does not describe compounds as treatments and does not provide administration guidance, and buyers are expected to maintain the same standard in their own labeling, listings, and marketing.

Where this leaves a qualified buyer

If your entity is registered, your counsel has reviewed how your model and your copy classify the products you intend to stock, and your documentation practices are in place, the remaining decision is which supplier's paperwork you are willing to stand behind. That is the point at which reviewing the published COAs and submitting a Wholesale Partner Program application makes sense — with the licensing questions answered by your attorney and your state board first, not last.

For more on program structure and access, see the wholesale peptides program, the broader overview of do you need a license to sell peptides, and the form to apply for a wholesale account.